FINANCIAL MARKETS
NEW YORK—U.S. stocks dodged bigger losses and finished barely lower on Wednesday. Health care companies fell and Apple pulled technology companies down, but banks rose.
Earlier in the day, stocks had appeared to be headed for a second day of notable losses, but they recovered some of that lost ground in late trading. Weak earnings for major companies hurt real estate investment trusts and health care companies. Tech stocks slid as investors were unimpressed with Apple’s latest results.
Stocks haven’t made many big moves the last two weeks. “Trading volume has really dropped off,” said Scott Wren, a senior global equity strategist at the Wells Fargo Investment Institute. He said investors are being cautious as they wait for the outcome of November’s election.
The Dow Jones industrial average added 30.06 points, or 0.2 percent, to 18,199.33. In early trading it fell more than 100 points. The Standard & Poor’s 500 index sank 3.73 points, or 0.2 percent, to 2,139.43. The Nasdaq composite shed 33.13 points, or 0.6 percent, to 5,250.27.
While individual companies might rise or fall based on their earnings, Wren said investors don’t care that much if overall corporate profits rise or fall this quarter. Earnings have been falling for more than a year but the drops are getting smaller.
Apple sank $2.66, or 2.2 percent, to $115.59 after it reported another drop in iPhone sales. Apple gets about twothirds of its revenue from the iPhone and some investors are concerned it depends too much on its marquee product. The company expects sales to start growing again in the holiday season after a recent slump.
The losses for Apple, by far the biggest company in the S&P 500, sent tech stocks lower. That canceled out big jumps in Akamai Technologies and Juniper Networks, which each surged more than 10 percent after strong results.
The price of oil fell for the third day in a row. U.S. crude fell 78 cents, or 1.6 percent, to $49.18 a barrel. Brent crude, the international standard, lost 81 cents, to 1.6 percent, to $49.98 a barrel in London.
Drugmaker Mylan fell after Kaleo Pharmaceuticals said it will resume selling its emergency allergy shot Auvi-Q next year. That would mean more competition for Mylan’s EpiPen. Auvi-Q was taken off the market last year because of the potential for inaccurate dosing, leaving EpiPen without any direct competition.
Mylan lost 70 cents, or 1.6 percent, to $38.08. The stock is down 22 percent since mid-August as the company has come under fire for repeatedly raising the price of the EpiPen over the last decade and for overcharging the government for the shot.
In other energy trading, wholesale gasoline slid 2 cents to $1.48 a gallon. Heating oil lost 1 cent to $1.55 a gallon. Natural gas fell 4 cents to $2.73 per 1,000 cubic feet.